Peculiarities of hemostasis changes under the influence of different regimens of antiplatelet therapy in patients with Q-wave myocardial infarction

QR Code

Peculiarities of hemostasis changes under the influence of different regimens of antiplatelet therapy in patients with Q-wave myocardial infarction

Aim. In order to study the influence of different regimens of antiplatelet therapy on the state of coagulation and aggregation hemostasis, intracardiac hemodynamics, incidence of post-infarction aneurysm and thrombus formation in the left ventricular cavity in patients with Q-wave myocardial infarct...

Full description

Saved in:

Bibliographic Details
Main Author:	S. M. Kyselov
Format:	Article
Language:	English
Published:	Zaporizhzhia State Medical and Pharmaceutical University 2014-12-01
Series:	Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki
Subjects:	Myocardial Infarction Protein C von Willebrand Factor Adhesion Molecules
Online Access:	http://pat.zsmu.edu.ua/article/view/36635/32806
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Endothelial activation markers (VCAM-1, vWF) in patients with chronic hepatitis C and insulin resistance
by: T. V. Antonova, et al.
Published: (2014-09-01)

Cardiorenal relationships in the focus of risks of atrial fibrillation in patients after acute ST-elevated myocardial infarction (observational program FAKEL)
by: I. A. Zolotovskaya, et al.
Published: (2019-05-01)

Probing rare von Willebrand disease–causing mutations in the D4 and C-domains of von Willebrand factor
by: Golzar Mobayen, et al.
Published: (2025-05-01)

The effects of various streptokinase thrombolysis regimens on coagulation hemostasis and fibrinolysis in acute myocardial infarction
by: Ya. L. Gabinsky, et al.
Published: (2006-12-01)

VASCULAR BED PECULIAR PROPERTIES IN PATIENTS WITH ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSION. ROLE OF ANTIPLATELET THERAPY
by: L. A. Haisheva, et al.
Published: (2016-01-01)

Pharmaceutical therapy programme for remodeling heart prevention after Q-wave myocardial infarction
by: R. M. Gafurova, et al.
Published: (2007-02-01)

Pharmaceutical therapy programme for remodeling heart prevention after Q-wave myocardial infarction
by: R. M. Gafurova, et al.
Published: (2007-02-01)

Features of coronary heart disease in a cohort of tajik patients and the condition of the vascular endothelium in its different clinical forms
by: F. A. Shukurov, et al.
Published: (2024-06-01)

Study of the state of th vascular endothelium in various forms of coronary heart disease
by: F. A. Shukurov, et al.
Published: (2023-09-01)

CLINICAL AND FUNCTIONAL CHARACTERISTICS OF PATIENTS AFTER Q-WAVE MYOCARDIAL INFARCTION DEPENDING ON THE METABOLIC SYNDROME PRESENCE OR ABSENCE
by: R. D. Kurbanov, et al.
Published: (2015-09-01)

Prognostic value of von Willebrand factor in clinical practice
by: K. N. Grigoreva, et al.
Published: (2022-11-01)

Additional risk factors of ventricular repolarization asynchrony in Q-wave myocardial infarction
by: L. E. Lagunina, et al.
Published: (2007-06-01)

EFFICACY OF ROSUVASTATIN IN DYSLIPIDEMIA CORRECTION IN PATIENTS AFTER Q-WAVE MYOCARDIAL INFARCTION
by: R. D. Kurbanov, et al.
Published: (2015-09-01)

Hyperhomocysteinemia, intravascular hemostasis disturbances, and clinical course of myocardial infarction
by: V. A. Lusov, et al.
Published: (2007-04-01)

Echocardiographic parameters of the left ventricle in patients after Q-wave and non-Q-wave myocardial infarction
by: V. E. Oleynikov, et al.
Published: (2024-03-01)

Clinical effectiveness of thrombolytic therapy with alteplase and double antiplatelet therapy in acute myocardial infarction
by: D. N. Kuznetsov, et al.
Published: (2011-12-01)

Endothelial dysfunction and hemostasis in acute myocardial infarction before and after Trombovazim therapy
by: Ye. F. Kotovshchikova, et al.
Published: (2011-02-01)

COMBINATION OF THE ULCERATIVE COLITIS AND VON WILLEBRAND DISEASE (A CASE REPORT)
by: I. A. Grishechkina, et al.
Published: (2017-08-01)

Eric Adolf von Willebrand
by: N. A. Makatsariya
Published: (2021-11-01)

A Review of Desmopressin Use in Bleeding Disorders: An Unsung Hero?
by: Benjamin Reardon, et al.
Published: (2025-07-01)

Prognostic importance of dispersion of interval Q-T electrocardiograms in patients with myocardial infarction
by: A. T. Teplyakov, et al.
Published: (2006-03-01)

PECULIARITIES OF PURINE METABOLISM AND LIPID PEROXIDATION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
by: E. V. Horolets, et al.
Published: (2016-01-01)

Distant inferior myocardial infarction with pathological Q-wave: a clinical case
by: K. G. Pereverzeva, et al.
Published: (2025-04-01)

PROLONGED DUAL ANTIPLATELET THERAPY AFTER MYOCARDIAL INFARCTION: WHAT THE RESULTS OF THE PEGASUS-TIMI 54 TRIAL SHOW
by: I. S. Yavelov
Published: (2017-09-01)

THE INVOLVEMENT OF ENDOTHELIAL DYSFUNCTION MARKERS IN THE PATHOGENESIS OF CHRONIC GLOMERULONEPHRITIS
by: T.V. Margieva, et al.
Published: (2006-03-01)

Pharmaceutical therapy of Q-wave acute myocardial infarction: effects on adrenal morphology and function
by: Yu. V. Rogovskaya, et al.
Published: (2008-04-01)

Vasospastic angina — vasospastic myocardial infarction
by: A. S. Galyavich, et al.
Published: (2020-03-01)

The impact of systemic changes on quality of care providing in acute myocardial infarction in Ukraine
by: S.М. Kyselov, et al.
Published: (2022-09-01)

Clinical significance of measuring ADAMTS-13, its inhibitor and von Willebrand factor in obstetric and gynecological practice
by: K. N. Grigoreva, et al.
Published: (2021-03-01)

Factor fon Willebrand antigen in endothelium functional state assessment in patients with systemic lupus erythematosus
by: M E Zapryagaeva, et al.
Published: (2004-06-01)

Vascular-type heterogeneity is associated with differential gene expression profiles of endothelial cells under shear stress
by: Allaura A. Cox, et al.
Published: (2025-05-01)

Myocardial infarction and Turner syndrome
by: A. S. Galyavich, et al.
Published: (2019-04-01)

The five-year survival of patients with various components of metabolic syndrome after Q-myocardial infarction
by: N. S. Mikhaylovska
Published: (2014-08-01)

FREQUENCY OF OCCURRENCE OF RISK FACTORS AND ADHERENCE TO DRUG THERAPY IN YAKUTS WHO UNDERWENT Q-POSITIVE MYOCARDIAL INFARCTION
by: E. S. Kylbanova, et al.
Published: (2018-08-01)

Data on the care and prognosis of patients treated for myocardial infarction. Hungarian Myocardial Infarction Registry 2024
by: András Jánosi
Published: (2025-07-01)

Acute myocardial infarction in the postpartum period in the young woman with protein C deficiency
by: E. S. Eniseeva, et al.
Published: (2018-04-01)

MYOCARDIAL INFARCTION AND HEMOPHILIA
by: A. S. Galyavich, et al.
Published: (2016-03-01)

THE CASE OF Q-WAVE MYOCARDIAL INFARCTION IN A 35-YEARS-OLD FEMALE
by: A. B. Tashtanaliev, et al.
Published: (2012-04-01)

A Novel Electrocardiographic Approach for Accurate Diagnosis of Prior Inferior Myocardial Infarction
by: Hailei Liu, MD, et al.
Published: (2025-08-01)

THROMBOLYTIC THERAPY IN PATIENTS WITH MYOCARDIAL INFARCTION
by: G. P. Ishmurzin, et al.
Published: (2010-12-01)